Literature DB >> 11561964

Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden.

B Evengård1, K Petersson, M L Engman, S Wiklund, S A Ivarsson, K Teär-Fahnehjelm, M Forsgren, R Gilbert, G Malm.   

Abstract

To estimate the burden of disease due to congenital toxoplasmosis in Sweden the incidence of primary infections during pregnancy and birth prevalence of congenital toxoplasmosis in 40,978 children born in two regions in Sweden was determined. Women possibly infected during pregnancy were identified based on: 1, detection of specific IgG based on neonatal screening of the phenylketonuria (PKU) card blood spot followed by retrospective testing of stored prenatal samples to detect women who acquired infection during pregnancy and follow up of their children to 12 months: 2, detection of specific IgM on the PKU blood spot. The birth prevalence of congenital toxoplasmosis was 0.73/10,000 (95 % CI 0.15-2.14) (3/40,978). The incidence of primary infection during pregnancy was 5.1/10,000 (95% CI 2.6-8.9) susceptible pregnant women. The seroprevalence in the southern part was 25.7% and in the Stockholm area 14.0%. The incidence of infection during pregnancy was low, as the birth prevalence of congenital toxoplasmosis. Neonatal screening warrants consideration in view of the low cost and feasibility.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561964      PMCID: PMC2869718          DOI: 10.1017/s0950268801005775

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established.

Authors:  R Gilbert; C Dezateux
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

2.  Can the common brain parasite, Toxoplasma gondii, influence human culture?

Authors:  Kevin D Lafferty
Journal:  Proc Biol Sci       Date:  2006-11-07       Impact factor: 5.349

Review 3.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

4.  Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy.

Authors:  B Pinto; B Castagna; R Mattei; R Bruzzi; L Chiumiento; R Cristofani; W Buffolano; F Bruschi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

5.  Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain.

Authors:  José M Ramos; Afredo Milla; Juan C Rodríguez; Sergio Padilla; Mar Masiá; Félix Gutiérrez
Journal:  Parasitol Res       Date:  2011-05-04       Impact factor: 2.289

6.  Increased seroprevalence of Toxoplasma gondii in a population of patients with Bell's palsy: a sceptical interpretation of the results regarding the pathogenesis of facial nerve palsy.

Authors:  Maria Riga; G Kefalidis; A Chatzimoschou; G Tripsianis; S Kartali; H Gouveris; M Katotomichelakis; V Danielides
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-09       Impact factor: 2.503

7.  The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.

Authors:  D R Schmidt; B Hogh; O Andersen; J Fuchs; H Fledelius; E Petersen
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

8.  Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.

Authors:  Mario Cortina-Borja; Hooi Kuan Tan; Martine Wallon; Malgorzata Paul; Andrea Prusa; Wilma Buffolano; Gunilla Malm; Alison Salt; Katherine Freeman; Eskild Petersen; Ruth E Gilbert
Journal:  PLoS Med       Date:  2010-10-12       Impact factor: 11.069

9.  Symptomatic toxoplasma infection due to congenital and postnatally acquired infection.

Authors:  R Gilbert; H K Tan; S Cliffe; E Guy; M Stanford
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

10.  Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.

Authors:  P Valentini; D Buonsenso; G Barone; D Serranti; R Calzedda; M Ceccarelli; D Speziale; R Ricci; L Masini
Journal:  J Perinatol       Date:  2014-09-11       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.